Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

Stock not shooting up because Remdesivir is OVERRATED.....scientists

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
I_luv_cydy Member Profile
 
Followed By 4
Posts 383
Boards Moderated 0
Alias Born 06/24/16
160x600 placeholder
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 8/7/2020 4:02:04 PM
Pfizer to Manufacture Gilead's Remdesivir for Covid-19 Treatment -- Update Dow Jones News - 8/7/2020 1:47:00 PM
Pfizer to Manufacture Gilead's Remdesivir for Covid-19 Treatment Dow Jones News - 8/7/2020 11:32:00 AM
Pfizer, Gilead in Agreement to Manufacture Remdesivir for Covid-19 Dow Jones News - 8/7/2020 9:16:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 4:08:37 PM
Gilead Shows the Dangers of Covid-19 Drug Mania -- Heard on the Street Dow Jones News - 8/3/2020 7:29:00 AM
Gilead Swings to Quarterly Loss on Higher Costs -- Update Dow Jones News - 7/30/2020 8:27:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2020 6:58:48 PM
Gilead Swings to Quarterly Loss on Higher Costs Dow Jones News - 7/30/2020 5:33:00 PM
Gilead Revises Annual Guidance Dow Jones News - 7/30/2020 5:17:00 PM
Gilead Swings to 2Q Loss Following Acquisition and Manufacturing Expansion of Covid-19 Drug Remdesivir Dow Jones News - 7/30/2020 4:46:00 PM
Gilead Sciences Announces Third Quarter 2020 Dividend Business Wire - 7/30/2020 4:02:00 PM
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results Business Wire - 7/30/2020 4:01:00 PM
FDA Nears Decision Authorizing Covid-19 Treatment With Convalescent Plasma -- Update Dow Jones News - 7/29/2020 5:33:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/28/2020 6:48:16 PM
Gilead Sciences & Satcher Health Leadership Institute at Morehouse School of Medicine Partner to Study Racial Health Inequiti... Business Wire - 7/28/2020 9:00:00 AM
U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma Business Wire - 7/24/2020 1:25:00 PM
Gilead, Galapagos Say Arthritis Drug Gets Recommendation to Start Marketing in Europe Dow Jones News - 7/24/2020 9:14:00 AM
Gilead & Galapagos Announce Positive European CHMP Opinion for Jyseleca® (Filgotinib) for the Treatment of Adults With Moder... Business Wire - 7/24/2020 8:10:00 AM
Gilead Buying Initial 49.9% Stake in Tizona Therapeutics for $300 Million Dow Jones News - 7/21/2020 9:17:00 AM
Breakthroughs and Advancements in Pathogen Detection Offer Hope as Virus Cases Surge NetworkNewsWire - 7/21/2020 8:45:00 AM
Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million Business Wire - 7/21/2020 8:30:00 AM
Russian Hackers Blamed for Attacks on Vaccine-Related Targets -- Update Dow Jones News - 7/16/2020 5:41:00 PM
Gilead Sciences to Release Second Quarter 2020 Financial Results on Thursday, July 30, 2020 Business Wire - 7/16/2020 4:01:00 PM
Russian Hackers Blamed for Attacks on Vaccine-Related Targets -- Update Dow Jones News - 7/16/2020 1:18:00 PM
I_luv_cydy   Thursday, 04/30/20 12:31:40 PM
Re: fung_derf post# 3626
Post # of 4311 
Stock not shooting up because Remdesivir is OVERRATED.....scientists already questioning the results....

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist